DIVIS LABORATORIES Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES Quarterly Results    (DIVI)

Here are the latest quarterly results of DIVIS LABORATORIES. For more details, see the DIVIS LABORATORIES financial fact sheet and DIVIS LABORATORIES share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

DIVIS LABORATORIES Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m13,96313,89717,30517,49317,01417,88219,60619,875 
Other income Rs m417767173136193235360191 
Turnover Rs m14,37914,66417,47817,62917,20818,11719,96620,066 
Expenses Rs m9,0249,45310,30410,08210,10210,71911,08611,694 
Gross profit Rs m4,9394,4457,0017,4116,9127,1638,5218,181 
Depreciation Rs m467498562611682701733774 
Interest Rs m164223232 
Profit before tax Rs m4,8734,7106,6106,9356,4216,6958,1457,596 
Tax Rs m1,2828271,6891,7391,7151,6752,5741,532 
Profit after tax Rs m3,5913,8824,9215,1964,7065,0205,5716,065 
Gross profit margin %35.432.040.542.440.640.143.541.2 
Effective tax rate %26.317.625.625.126.725.031.620.2 
Net profit margin %25.727.928.429.727.728.128.430.5 
Diluted EPS Rs 13.5 14.6 18.5 19.6 17.7 18.9 21.0 22.8  
Diluted EPS (TTM) Rs NA 51.9 60.1 66.3 70.5 74.7 77.2 80.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

Read: DIVIS LABORATORIES 1QFY22 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   BALAXI PHARMA  ALKEM LABORATORIES  STRIDES PHARMA SCIENCE  CONCORD DRUGS  ALCHEMIST LIMITED  

Compare DIVIS LABORATORIES With:   BALAXI PHARMA  ALKEM LABORATORIES  STRIDES PHARMA SCIENCE  CONCORD DRUGS  ALCHEMIST LIMITED  



Today's Market

Sensex Soars 620 Points, Nifty Ends Above 17,150; IndusInd Bank & JSW Steel Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Dec 1, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - ADCOCK INGRAM COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS